Cardiol Therapeutics Inc. ( CRDL) - Key Metrics
CRDL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.08 | $0 | $0 |
| 2026Q1 | $0 | -$0.10 | -$0.07 | -$0.07 |
| 2025Q4 | $0 | -$0.07 | -$0.05 | -$0.05 |
| 2025Q3 | $0 | -$0.12 | -$0.08 | -$0.08 |
| 2025Q2 | $0 | -$0.10 | -$0.06 | -$0.06 |
CRDL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.29 |
| 2026Q1 | 0% | -4.72 |
| 2025Q4 | 0% | -4.55 |
| 2025Q3 | 0% | -3.10 |
| 2025Q2 | 0% | -4.62 |
CRDL
Price: $1.32
52 week price:
Earnings Per Share: -0.25 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 88200
Market Capitalization: 248.4 million